Nara Capital
Overview
Nara Capital is a multi-strategy investment firm based in Barcelona, Spain, with investment strategies focused on venture capital, health, and sustainability.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Aortyx | Jun 2025 | Series A | Co-investor |
| Tesai Care | Dec 2024 | Seed | Lead |
| Affirma Biotech | Feb 2024 | VC Round | Lead |
| MiMARK Diagnostics | Nov 2023 | Seed | Co-investor |
| Gyala Therapeutics | Sep 2025 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Daniel Oliver
Partner
Miguel Eguizabal Abad
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Nara Capital based?
Nara Capital is headquartered in Barcelona, Spain.
When was Nara Capital founded?
Nara Capital was founded in 2022.
How many portfolio companies does Nara Capital have?
Nara Capital has 8 portfolio companies in Caplight's dataset.
What are some companies in Nara Capital's portfolio?
Portfolio companies visible on Caplight include Aortyx, Tesai Care, Affirma Biotech, MiMARK Diagnostics, Gyala Therapeutics.
What was Nara Capital's most recent investment shown here?
Nara Capital's most recent investment in this portfolio sample was in Gyala Therapeutics in 2025.
What sectors does Nara Capital focus on?
Nara Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Real Estate & PropTech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Nara Capital focus on?
Nara Capital typically invests at the Early stage.
What is Nara Capital's AUM?
Nara Capital's assets under management are estimated at over $110.0M.